Enhertu plus pertuzumab approved in the US as first new treatment in a decade for...

AstraZeneca Pharma India gets CDSCO nod for Datopotamab deruxtecan for treating metastatic breast cancer

DATROWAY Type II Variation Application validated in the EU as first-line treatment for patients with...

JSKN003 was granted Breakthrough Therapy Designation by the FDA for the treatment of PROC

Huadong Medicine announced that HDM2012 has received Orphan Drug Designation (ODD) from the U.S. Food...

Cellectar Biosciences announces strategic supply agreement with Lonetix for Actinium-225 and Astatine-211 to advance targeted...